In addition, a study performed by using a confocal laser microscope demonstrated a co-expression of Polycomb BMI1 protein and CD26+ antigen on CD34+/CD38− LSCs of BM samples of CML at diagnosis and during treatment with imatinib [49]. This evidence concerns the gene DPP4 and chronic myelogenous leukemia, BCR-ABL1 positive.